Other Diseases Caused by Protozoan

  • F. J. H. N. Braga
Part of the Developments in Nuclear Medicine book series (DNUM, volume 34)

Abstract

Malaria (also known as paludism) is caused by 4 species of parasites (plasmodia). Disease is transmitted to man by anopheline mosquitoes. Plasmodium falciparum causes the most dangerous form of disease. Malaria is the most important cause of fever and morbidity in the tropical world. In tropical Africa, it is estimated that 400 million people live in endemic areas. The number of clinical malaria was estimated at 75-150 million people in the beginning of the 1990’s. A total of 6,5 million cases occurred outside tropical Africa in 1982. Disease kills 1-3 million people yearly in the world. Malaria has recently been detected in Europe and the USA. Amidst 4,000 Barawan refugees resettling to the United States, 26 were infected by plasmodia (63). The total incidence or reported numbers of malaria infections in Europe increased from 6,840 in 1985 to 7,244 in 1995, with a peak of 8,438 in 1989. The most important importing countries were France, Germany, Italy, and the United Kingdom. In falciparum malaria, the most frequently affected organs are brain, kidneys, lungs and liver. Complicated cerebral malaria causes death in 50% of the cases. A rate of 20% of residual disability is detected in survivors. The role of MRI in brain malaria is well established (64-72). The volume of the brain in patients with acute cerebral malaria is increased, as compared to the volume during the convalescent phase of the disease, which probably results from sequestration of infected erythrocytes and compensatory vasodilatation, rather than from oedema (73). Cerebral volume is smaller during early convalescence than several months later. Focal areas of infarction are frequently seen and temporal lobes and hippocampus are more often affected.

Keywords

Radionuclide Malaria Cardiomyopathy Cardiol Thallium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Marin Neto JA, Simoes MV, Sarabanda AVL. Chagas’ Heart Disease. Arq Bras Cardiol 1999; 72: 264–280.CrossRefGoogle Scholar
  2. 2.
    Marin Neto JA. Etiology, pathology and pathogenesis of Chagas’ disease. In: Up To Date in Cardiovascular Medicine, a CD-ROM Textbook. Rose BD, Podrid PJ, Gersh BJ (eds.). Up To Date in Medicine, Inc, Vol. 6, N“ I, Wellesley, MA. USA. 2001.Google Scholar
  3. 3.
    Marin Neto JA, Simôes MV, Maciel BA. Specific diseases: cardiomyopathies and pericardial diseases. Other Cardiomyopathies. In Yusuf S, Cairns J, Camm J, Fallen E, Gersh BJ (eds). Evidence Based Cardiology. London, GB. BMJ Books, Brit Med Association 1998; 744–61.Google Scholar
  4. 4.
    Wanderley, DM, Correa, FM. Epidemiology of Chagas’ heart disease. Rev Paul Med 1995; 113:742.Google Scholar
  5. 5.
    Schofield, CJ, Dias, JC. A cost benefit analysis of Chagas disease control. Mem Inst Oswaldo Cruz 1991; 86:285.PubMedCrossRefGoogle Scholar
  6. 6.
    WHO. Control of Chagas Disease. xxxxx Geneva. WHO Technical Report Series 1991; 811: 95p.Google Scholar
  7. 7.
    Kirchhoff, LV, Gam, AA, Gilliam, FC. American trypanosomiasis (Chagas’ disease) in Central American immigrants. Am J Med 1987; 82: 915.PubMedCrossRefGoogle Scholar
  8. 8.
    Hagar, JM, Rahimtoola, SH. Chagas’ heart disease. Curr Probl Cardiol 1995; 20: 825.PubMedGoogle Scholar
  9. 9.
    Rassi Jr A, Marin-Neto JA. Chronic Chagas’ heart disease. State of the art. Rev Socesp 2001.Google Scholar
  10. 10.
    Marin-Neto JA, Maciel BC, Simôes MV. Clinical aspects of Chagas’ heart disease. In: Rose BD, Podrid PJ, Gersh BJ, (eds). Up To Date in Cardiovascular Medicine, CD-ROM textbook.1999Google Scholar
  11. 11.
    Marin-Neto JA, Simôes MV, Ayres-Neto EM, Attab-Santos JL, Gallo Jr L, Amorim DS, Maciel BC. Studies of the coronary circulation in Chagas’ heart disease. Sao Paulo Med J RPM 1995; 113: 826–34.Google Scholar
  12. 12.
    Andrade ZA. Patologia da Doença de Chagas. InTrypanosoma cruzie Doença de Chagas. Brener Z, Andrade ZA, Barral Neto M (eds). Guanabara Koogan 2000; 201–30.Google Scholar
  13. 13.
    Gallo Jr L, Marin-Neto JA, Manço JC, Rassi A, Amorim DS. Abnormal heart rate responses during exercise in patients with Chagas’ disease. Cardiology 1975; 60: 147–62.PubMedCrossRefGoogle Scholar
  14. 14.
    Carrasco HA, Barboza JS, Inglessis G, Fuenmayor A, Molina C. Left ventricular cineangiography in Chagas’ disease: detection of early myocardial damage. Am Heart J 1982; 104: 595–601.PubMedCrossRefGoogle Scholar
  15. 15.
    Hammermeister KE, Caeiro T, Crespo E, Palmero H, Gibson D. Left ventricular wall motion in patients with Chagas’ disease. Br Heart J 1984; 51: 70–6.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Acquatella H, Schiller NB, Puigbó JJ. M-mode and two-dimensional echocardiography in chronic Chagas’ disease. A clinical and pathologic study. Circulation 1980; 62: 787–99.CrossRefGoogle Scholar
  17. 17.
    Kushnir E, Sgammini H, Castro R, Ledesma RE, Evequoz C. Miocardiopatia Chagásica cronica: efectos del dipiridamol sobre la dinamica ventricular. Arq Bras Cardiol 1983; 41: 373–8.Google Scholar
  18. 18.
    Kushnir E, Sgammini H, Castro R, Evequoz C, Ledesma RE, Brunetto J. Valoracion de la funcion cardiaca por angiografia radioisotopica en pacientes con cardiopatia chagasica cronica. Arq Bras Cardiol 1985; 45: 249–56.Google Scholar
  19. 19.
    Arreaza N, Puigbó JJ, Acquatella H, Casal H, Giordano H, Valecillos R, Mendoza I, Pérez JF, Hirschhaut E, Combellas I. Radionuclide evaluation of left ventricular function in chronic Chagas’ cardiomyopathy. J Nucl Med 1983; 24: 563–7.PubMedGoogle Scholar
  20. 20.
    Marin-Neto JA, Marzullo P, Cousa ACS, Marcassa C, Maciel BC, lazigi N, L’Abbate A. Radionuclide angiographie evidence for early and predominant right ventricular involvement in patients with Chagas’ disease. Can J Cardiol 1988:4: 231–6.PubMedGoogle Scholar
  21. 21.
    Marin Neto JA, Marzullo P, Marcassa C, Gallo Jr L, Maciel BC, Belina R, L’Abbate A. Perfusion defects detected by Thallium-201 scintigraphy in Chagas’ Heart Disease. Am J Cardiol 1992; 69: 780–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Barreto AC, Azul LG, Mady C, lanniBMBrito-Vianna C, Belloti G, Pileggi F. Indeterminate form of Chagas’ disease apolymorphic disease Arq Bras Cardiol 1990; 55: 347–53.Google Scholar
  23. 23.
    Oliveira JSM, Oliveira JAM, Frederigue Jr U, Lima Filho EC. Apical aneurysm of Chagas’ heart disease. Br Heart J 1981; 46: 432–7.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Paola AA, Balbao CE, Castigiolni ML, Barbieri A, Mendonça A, Netto OS, Guiguer Junior N, Vattimo AC, Souza IA, Portugal OP. Radioisotopic mapping of the arrhythmogenic focus in patients with chronic chagasic cardiomyopathy and sustained ventricular tachycardia. Arq Bras Cardiol 1993; 60: 373–6.PubMedGoogle Scholar
  25. 25.
    Sarabanda AVL, Marin-Neto JA, Simáes MV, Geraldo Figueiredo G, Pintya AO, xxxxx Sosa EA. PACE 2001; 24:723 (A737).Google Scholar
  26. 26.
    Marin-Neto JA, Bromberg-Marin G, Pazin-Filho A, Simóes, MV, Maciel BC. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas’ disease. Int J Cardiol 1998; 65:261–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Simiïes MV, Pazin-Filho A, Marin GB, Maciel BC, Marin-Neto JA. Early myocardial damage detected by radionuclide angiography evaluation of patients with the indeterminate phase of Chagas’ Disease. XIII World Congress of Cardiology, Rio de Janeiro, Brazil. April 1998. J American Coll Cardiol 1998; 31: A2813.Google Scholar
  28. 28.
    Simóes MV, Soares FA, Marin-Neto JA. Severe myocarditis and esophagitis during reversible long standing Chagas’ disease recrudescence in immune-compromised host. Int J Cardiol 1995; 49: 271–3.PubMedCrossRefGoogle Scholar
  29. 29.
    Kuschnir E, Kustch F, Epelman M, Santamarina N, Podio RB. Valoracion del flujo miocardico corn Rb86, en pacientes com cardiopatia chagasica, con insuficiencia coronaria y en controles normales. Parte 1: Estudos Basales. Arq Bras Cardiol 1974; 27: 187–96.Google Scholar
  30. 30.
    Kuschnir E, Kustich F, Epelman MN, Podio RB. Estudios del flujo miocardico en patientes con insuficiencia coronaria y en patients corn cardiopatia chagasica cronica. Respuesta a la administración de dinitrato de isosorbide y dipiridamol. Prensa Med Argentina 1984; 60: 637–50.Google Scholar
  31. 31.
    Hagar JM, Rahimtoola SH, Tubau JF. Chagas’ heart disease in the USA: thallium abnormalities mimic coronary artery disese. Circulation 1991; 84: 1–631.Google Scholar
  32. 32.
    Marin-Neto JA, Marzullo P, Ayres-Neto E. Miocardial perfusion disturbances detected by 99mTc-microspheres in Chagas patients with angiographically normal coronary arteries. Circulation 1995; 92: 2250.Google Scholar
  33. 33.
    Kinoshita T, Itoh H, Takahashi K, Takeda H. Myocardial imaging with 1–123 MIBG and T1201 demonstrates denervated but viable myocardium in a patient with myocarditis. Clin Nucl Med 1994; 19: 649–50.PubMedCrossRefGoogle Scholar
  34. 34.
    Simóes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antologa CM, Pazin Filho A, Maciel BC, Marin Neto JA. Relation of regional sympathetic denervation and myocardial perfusion disturbances to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol 2000; 86:985–91.CrossRefGoogle Scholar
  35. 35.
    Hagar JM, Rahintoola SH. Chagas’ disease in the United States. New Engl J Med 1991; 325: 763–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Milei J, Mautner B, Storino R, Sanchez JA, Ferrans VJ. Does Chagas’ disease exist as an undiagnosed form of cardiomyopathy in the United States? Am Heart J 1992; 123: 1732–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Reyes PA. Chagas’ disease in the United States. Am Heart J 1992; 123: 1724.PubMedCrossRefGoogle Scholar
  38. 38.
    Kirchhoff LV. American Tripanosomiasis (Chagas’ disease) in the US _ a tropical disease now in the United States. New Engl J Med 1993; 329: 369–74.Google Scholar
  39. 39.
    Ueno Y, Nakamura Y, Takahashi M, Inoue T, Endo S, Kinoshita M, Takeuchi T. A highly suspected case of chronic Chagas’ heart disease diagnosed in Japan. Jpn Circ J 1995; 59: 219–23.PubMedCrossRefGoogle Scholar
  40. 40.
    Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas’ disease, in US blood donors. J Infect Dis 1997; 176: 1047–52.PubMedCrossRefGoogle Scholar
  41. 41.
    Meurs KM, Anthony MA, Slater M, Miller MW. Chronic Trypanosoma cruzi infection in dogs: 11 cases (1987–1996). J Am Vet Med Assoc 1998; 213: 497–500.PubMedGoogle Scholar
  42. 42.
    Oliveira RB, Troncon LEA, Dantas RO, Meneghelli UG. Gastointestinal manifestations of Chagas’ disease. Am J Gasteoenterol 1998; 93: 884–9.CrossRefGoogle Scholar
  43. 43.
    Dias JCP. Acute Chagas’ disease. Mem Inst Oswaldo Cruz 1984; 79: 85–92.CrossRefGoogle Scholar
  44. 44.
    Van Voorthis W, Schekelewy L, Trong H. Molecular mimicry byTripanossoma cruzi:the Fl-160 epitope that mimics mammalian nerve can be mapped into a 12 amino-acid peptide. Proc Nat Acad Sci USA 1991; 86: 5993–7.CrossRefGoogle Scholar
  45. 45.
    Koeberle F, Brito Costa, Melo de Oliveira JA. Patologia da Doença de Chagas. Medicina Ribeirao Preto 1972; 5: 5–45.Google Scholar
  46. 46.
    Troncon LEA, Oliveira RB, Romanello LMF. Abnormal progression of a liquid meal through the stomach and small intestine in patients with Chagas-Disease. Dig Dis Sci 1993; 38: 1511–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Koeberle F. Chagas’ disease and Chagas’ syndromes. The pathology of American tripanosomiasis. Adv Parasitol 1968; 6: 63–73.CrossRefGoogle Scholar
  48. 48.
    Rezende JM, Rossi A. Manifestaçôes digestivas na fase aguda da Doença de Chagas. In Manifestaçoes digestivas da moléstia de Chagas, ed: Arrigo Antonio Raia. 1983. Sarvier Editora de livros Médicos, Sao Paulo, 97–107.Google Scholar
  49. 49.
    Marioni-Filho H, Thom AF, Martins LR. Initial results of the study of megaesophagus with Te 99m scintigraphy. Preliminary note. Rev Inst Med Trop Sao Paulo 1980; 22: 209–11.PubMedGoogle Scholar
  50. 50.
    Marioni-Filho H, Martins LR, Boainain E, Thom AF. Study of oesophageal dynamics by scintigraphy as a possible method for the early diagnosis of aperistalsis in patients with Chagas’ disease. Rev Inst Med Trop Sao Paulo 1984; 26: 130–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Oliveira RB, Rezende Filho J, Dantas RO, lazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol 1995; 90: 1119–24.PubMedGoogle Scholar
  52. 52.
    Souza MAN, Dantas RO, Oliveira RB, Braga FJHN. Scintigraphic study of oropharyngeal swallowing dynamics in Chagas’ disease. Dig Dis Scien 1998; 43: 1595.Google Scholar
  53. 53.
    Souza MAN, Dantas RO, Oliveira RB, Braga FJHN. A scintigraphic study of oro-pharyngeal swallowing dynamics in Chagas’ disease. Neurogastroenterol Mot 2000; 12: 335–41.CrossRefGoogle Scholar
  54. 54.
    Rezende Filho J, Oliveira RB, Dantas RO, lazigi N. Efeito do dinitratto de isossorbitol sobre o esvaziamento esofagiano no megaesôfago Chásico. Arq Gastroenterol Sao Paulo 1990; 27: 115–9.Google Scholar
  55. 55.
    Oliveira RB, Matsuda NM, Figueiredo MCA, Okano N, Vargas E. Comparison of the effects of sublingual isosorbide dinitrate and cardiomyotomy on esophageal emptying in patients with Chagasic megaesophagus. Arg Gastroenterol Sao Paulo 1994; 31: 47–51.Google Scholar
  56. 56.
    Figueiredo MCA, Oliveira RB, lazigi N, Matsuda NM. Short report: comparison of the effects of sublingual nefedipine and isosorbide dinitrate on oesophageal emptying in patients with Chagasic achalasia. Aliment Pharmacol Ther 1992; 6: 507–12.PubMedCrossRefGoogle Scholar
  57. 57.
    Matsuda NM, Oliveira RB, Dantas RO, lazigi N. Effect of isosorbide dinitrate on gastroesophageal reflux in healthy volunteers and patients with Chagas’ disease. Dig Dis Sci 1995; 40: 177–82.PubMedCrossRefGoogle Scholar
  58. 58.
    Troncon LEA, lazigi N. Scintigraphic study of the gastrointestinal transit of a liquid meal in patients with Chagas-Disease. Braz J Med Biol Res 1992; 25: 145–8.PubMedGoogle Scholar
  59. 59.
    Troncon LEA, Oliveira RB, Romanello LMF, Rosa e Silva L, Pinto MCC, Iazigi N. Abnormal progression of a liquid meal through the stomach and small intestine in patients with Chagas’ disease. Dig Dis Sci 1993; 38: 1511–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Troncon LEA, Aprile LRO, Oliveira RB, lazigi N. Abnormally rapid gastric emptying of an isosmotic liquid meal in patients with megaduodenum. Dig Dis Sci 2000; 45: 2145–50.PubMedCrossRefGoogle Scholar
  61. 61.
    Troncon LAE, Rezende Filho J, lazigi. Duodenogastric reflux in Chagas’ disease. Dig Dis Sci 1988; 3: 1260–4.CrossRefGoogle Scholar
  62. 62.
    Troncon LEA, Rezende Filho J, lazigi N. Estudo cintilográfico do esvaziamento da vesícula biliar na doença de Chagas crônica. Arg Gastroenterol Sao Paulo 1987; 24: 157–63.Google Scholar
  63. 63.
    Miller JM, Boyd HA, Ostrowski SR, Cookson ST, Parise ME, Gonzaga PS, Addiss DG, Wilson M, Nguyen Dinh P, Wahlquist SP, Weld LH, Wainwright RB, Gushulak BD, Cetron MS. Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections. Am J Trop Med Hyg 2000; 62: 115–21.PubMedGoogle Scholar
  64. 64.
    Milian JM, San Milian JM, Munoz M, Navas E, Lopez Velez R. CNS complications in acute malaria: MR findings. Am J Neuroradiol 1993; 14: 493–4.Google Scholar
  65. 65.
    Kampfl AW, Birbamer GG, Pfausler BE, Haring HP, Schmutzhard E. Isolated pontine lesion in algid cerebral malaria: clinical features, management, and magnetic resonance imaging findings. Am J Trop Med Hyg 1993; 48: 818–22.PubMedGoogle Scholar
  66. 66.
    Saissy JM, Pats B, Renard JL, Dubayle P, Herve R. Isolated bulb lesion following mild Plasmodium falciparum malaria diagnosed by magnetic resonance imaging [letter]. Intensive Care Med 1996; 22: 610–1.PubMedCrossRefGoogle Scholar
  67. 67.
    Koch J, Strik WK, Becker T, Fleischer K, Gold R, Hofmann E. Acute organic psychosis after malaria tropica. Nervenarzt 1996; 67: 72–6.PubMedGoogle Scholar
  68. 68.
    Grote CL, Pierre Louis SJ, Durward WF. Deficits in delayed memory following cerebral malaria: a case study. Cortex 1997; 33: 385–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Schnorf H, Diserens K, Schnyder H, Chofflon M, Loutan L, Chaves V, Landis T. Corticosteroid-responsive postmalaria encephalopathy characterized by motor aphasia, myoclonus, and postural tremor. Arch Neurol 1998; 55: 417–20.PubMedCrossRefGoogle Scholar
  70. 70.
    Cordoliani YS, Sarrazin JL, Leveque C, Goasdoue P, Sabbah P. Imaging of encephalic parasitic diseases. J Neuroradiol 1998; 25: 290–305.PubMedGoogle Scholar
  71. 71.
    Cordoliani YS, Sarrazin JL, Felten D, Caumes E, Leveque C, Fisch A. MR of cerebral malaria. AJNR 1998; 19: 871–4.PubMedGoogle Scholar
  72. 72.
    Yasui K, Ito Y, Ando T, Yanagi T, Tsuzuki T, Yoshida M, Hashizume Y, Sobue G. An autopsy case of bilateral carotid artery occlusion with repetitive epilepsy and brain atrophy in a senile patient (clinical conference). No To Shinkei 2000; 52: 79–88.PubMedGoogle Scholar
  73. 73.
    Looareesuwan S, Wilairatana P, Krishna S, Kendall B, Vannaphan S, Viravan C, White NJ. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis 1995; 21: 300–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Ziessman HA. Lung uptake of 99mTc-sulfur colloid in falciparum malaria: case report. J Nucl Med 1976; 17: 794–6.PubMedGoogle Scholar
  75. 75.
    Da Costa H, Adatrao V, Merchant S. A radiocolloid study of the reticulo-endothelial system in tropical diseases. Nuklearmedizin 1979; 18: 130–2.PubMedGoogle Scholar
  76. 76.
    Leclerc Y, Verreault J, Bisson G. Diffuse lung uptake of technetium-99m sulfur colloid in malaria. J Nucl Med 1989; 30: 117–9.PubMedGoogle Scholar
  77. 77.
    Jabourian AP, Benhamou PA, Bitton R. Clinical imaging in psychiatry. Ann Med Psychol Paris 1996; 154: 74–7.PubMedGoogle Scholar
  78. 78.
    Kampfl A, Pfausler B, Haring HP, Denchev D, Donnemiller E, Schmutzhard E. Impaired microcirculation and tissue oxygenation in human cerebral malaria: a single photon emission computed tomography and near-infrared spectroscopy study. Am J Trop Med Hyg 1997; 56: 585–7.PubMedGoogle Scholar
  79. 79.
    David C, Dimier David L, Vargas F, Torrez M, Dedet JP. Fifteen years of cutaneous and mucocutaneous leishmaniasis in Bolivia: a retrospective study. Trans R Soc Trop Med Hyg 1993; 87: 7–9.PubMedCrossRefGoogle Scholar
  80. 80.
    Thakur CP, Kumar K. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 1992; 86: 355–9.PubMedGoogle Scholar
  81. 81.
    Santos EG, Marzochi MC, Conceicao NF, Brito CM, Pacheco RS. Epidemiological survey on canine population with the use of immunoleish skin test in endemic areas of human American cutaneous leishmaniasis in the state of Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 1998; 40: 41–7.PubMedCrossRefGoogle Scholar
  82. 82.
    Bora D. Epidemiology of visceral leishmaniasis in India. Natl Med J India 1999; 12: 62–8.PubMedGoogle Scholar
  83. 83.
    Pignatti MG, Mayo RC, Alves MJ, Souza SS, Macedo F, Pereira RM. American tegumentary leishmaniasis in the northeastern state of Sao Paulo-Brazil. Rev Soc Bras Med Trop 1995; 28: 243–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Walsh JF, Molyneux DH, Birley MH. Deforestation: effects on vector-borne disease. Parasitology 1993; 106: S55–75.PubMedCrossRefGoogle Scholar
  85. 85.
    Braga MIN, Rivitti MCM, Tedesco Marchesi LCM, Camargo EE, Gambini DJ, Banitault L. Contribution au début de l’étude de deux maladies infectieuses à l’aide de la scintigraphie au gallium-67: la lèpre et al leishmaniose cutanée et muqueuese. Bull Soc Path Exo Inst Pasteur 1992; 85: 53–7.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • F. J. H. N. Braga

There are no affiliations available

Personalised recommendations